Q32 Bio (QTTB) Accounts Payables (2017 - 2026)
Q32 Bio's (QTTB) quarterly Accounts Payables came in at $653000.0 in Q1 2026, down 75.92% year-on-year from $2.7 million in Q1 2025, and down 25.71% quarter-over-quarter from $879000.0 in Q4 2025.
Q32 Bio (QTTB) Accounts Payables (2017 - 2026) Analysis & Trends
Q32 Bio's Accounts Payables history runs 10 years deep, the most recent figure standing at $653000.0 for Q1 2026.
- On a quarterly basis, Accounts Payables fell 75.92% year-over-year to $653000.0 in Q1 2026; TTM through Mar 2026 was $653000.0, a 75.92% decrease from a year earlier, with the FY2025 full-year figure at $879000.0, down 70.59% from the prior year.
- Accounts Payables retreated to $653000.0 in Q1 2026 per QTTB's latest filing, from $879000.0 in the prior quarter.
- Across five years, Accounts Payables topped out at $9.9 million in Q1 2022 and bottomed at $653000.0 in Q1 2026.
- The 5-year median for Accounts Payables is $3.0 million (2024), against an average of $3.3 million.
- Across the five-year window, Accounts Payables jumped 203.15% in 2023 and sank 83.88% in 2024, its largest moves.
- Year by year, Accounts Payables stood at $1.1 million in 2022, then soared by 203.15% to $3.5 million in 2023, then slipped by 13.81% to $3.0 million in 2024, then tumbled by 70.59% to $879000.0 in 2025, then dropped by 25.71% to $653000.0 in 2026.
- Per Business Quant, the three latest QTTB Accounts Payables figures stand at $653000.0 (Q1 2026), $879000.0 (Q4 2025), and $973000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Q32 Bio | 225.00 Mn | 174.25 Mn | - | 653,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 653,000.00 |
| Dec 31, 2025 | 879,000.00 |
| Sep 30, 2025 | 973,000.00 |
| Jun 30, 2025 | 910,000.00 |
| Mar 31, 2025 | 2.71 Mn |
| Dec 31, 2024 | 2.99 Mn |
| Sep 30, 2024 | 1.26 Mn |
| Jun 30, 2024 | 2.48 Mn |
| Mar 31, 2024 | 4.96 Mn |
| Dec 31, 2023 | 3.47 Mn |
| Sep 30, 2023 | 7.80 Mn |
| Jun 30, 2023 | 3.39 Mn |
| Mar 31, 2023 | 3.64 Mn |
| Dec 31, 2022 | 1.14 Mn |
| Sep 30, 2022 | 4.84 Mn |
| Jun 30, 2022 | 3.76 Mn |
| Mar 31, 2022 | 9.89 Mn |
| Dec 31, 2021 | 2.37 Mn |
| Sep 30, 2021 | 3.52 Mn |
| Jun 30, 2021 | 5.70 Mn |